Biotech Eiger BioPharmaceuticals Announces U.S. Commercial Availability of Zokinvy(TM) (lonafarnib), the First and Only Treatment Approved for Progeria and Processing-Deficient Progeroid Laminopathies January 25, 2021
Biotech Abeona Therapeutics Announces Successful Type B Meeting with FDA for Pivotal Phase 3 VIITAL(TM) Study of EB-101 in Recessive Dystrophic Epidermolysis Bullosa (RDEB) January 25, 2021
Biotech Advaxis Reports Fiscal Year 2020 Financial Results and Provides a Business Update January 25, 2021
Biotech Citius Pharmaceuticals Announces $20.0 Million Private Placement Priced At-the-Market January 25, 2021
Biotech 2-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm January 25, 2021
Biotech FBIO Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 January 24, 2021
Biotech 3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm January 23, 2021
Biotech FBIO FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important Tuesday Deadline in Securities Class Action – FBIO January 23, 2021
Biotech BioLineRx Announces Closing of $34.5 Million Bought Deal Offering and Full Exercise of the Option of the Underwriter January 22, 2021
Search
Biotech
January 25, 2021
January 25, 2021
January 25, 2021
January 25, 2021
January 25, 2021
January 25, 2021
January 24, 2021
January 23, 2021
January 23, 2021
January 22, 2021
